Rechallenge with immune checkpoint inhibitors therapy for patients with HCC-lot more to learn

Hepatol Int. 2024 Dec;18(6):1712-1714. doi: 10.1007/s12072-024-10751-w. Epub 2024 Nov 20.

Author

George Lau^{1

2}

Affiliations

¹ Humanity and Health Clinical Trial Center, Humanity and Health Medical Group, Central, Hong Kong SAR, China. [email protected].
² Zhongshan Hospital, Fudan University, Shanghai, China. [email protected].

PMID: 39565539
DOI: 10.1007/s12072-024-10751-w

No abstract available

Keywords: Hepatocellular carcinoma; Immune checkpoint inhibitors; Rechallenge.

Publication types

Editorial